By Nigam Arora & Dr. Natasha Arora It is said to strike when the iron is hot. This is exactly what The Arora Report subscribers did with two complete portfolios. Coronavirus Recovery Portfolio Coronavirus Portfolio Substantial profits have already been booked. However, much greater profits are still unrealized. Hindsight proves
By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. Hotter Inflation Data Inflation erodes buying power. The government continues to claim there is no inflation or inflation is transitory. The government is simply wrong – in our analysis, the inflation
By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. Fed Meeting Please click here for a chart of the Consumer Price Index (CPI). Note the following: The chart shows that inflation is rising. The Fed claims that inflation is transitory.
By Nigam Arora & Dr. Natasha Arora Hello Friends, Thousands of investors have been using an RSS reader to get the Generate Wealth Newsletter from The Arora Report. Big changes are coming. You already know that The Arora Report has been the most accurate about the stock market, gold and
By Nigam Arora & Dr. Natasha Arora There are big rewards from investing in hot sectors. However, individual stocks in hot sectors present significant risks. Fortunately, there is a good way to reap the big rewards and at the same time reduce the risks. This can be accomplished by combining
By Nigam Arora & Dr. Natasha Arora Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules
By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know now. Record High Net Worth Please click here for a chart of Nasdaq 100 ETF (QQQ). Note the following: Thanks, Biden and Powell for the free money! The net worth of U. S. households has
By Nigam Arora & Dr. Natasha Arora The Arora Report typically gives target zones with the buy signals. The first target zone for Ocugen (OCGN) was $7.73 to $8.31. The stock hit $8 before pulling back. Per the system, all subscribers should have taken full profits and exited the position
By Nigam Arora & Dr. Natasha Arora Editor’s note: In this stock market, there are many opportunities to make significant money not based on fundamentals but with short term trades based on the known behavior of the momo crowd. Investors should consider taking advantage of such opportunities in addition to
By Nigam Arora & Dr. Natasha Arora For the first time in two decades, the FDA has approved a new Alzheimer’s drug. The drug is from Biogen (BIIB). There is a great unmet need for Alzheimer’s treatment. Can you imagine investors getting richer by correctly buying the stocks of companies